Biomarkers - PowerPoint PPT Presentation


Characterising Risk and Biology of Smouldering Myeloma for Early Detection of Symptomatic Myeloma

Understand the risk and biology of smouldering myeloma (SMM) for early detection of symptomatic myeloma. The study will investigate genomic and immune correlates of progression, clonal heterogeneity, and biomarkers using liquid biopsies and T cell phenotype and functionality in SMM.

4 views • 15 slides


Biomarker and Companion Diagnostics Event-20th - 21st June 2024 -Boston, USA

MarketsandMarkets brings to you the Biomarker and Companion Diagnostics Conference scheduled to be held on 20th - 21st June 2024 in Boston, USA. This event will have an introduction to turning biomarkers into companion diagnostics.\n\nEnquire Now @ https:\/\/events.marketsandmarkets.com\/2nd-annual-

4 views • 5 slides



Understanding Alinity i STAT High Sensitivity Troponin-I for Cardiovascular Diagnosis

Alinity i STAT High Sensitivity Troponin-I is a proprietary assay used in diagnosing myocardial infarction (MI) by quantitatively measuring cardiac troponin I in human plasma. This chemiluminescent microparticle immunoassay (CMIA) aids in the detection of MI, a significant aspect in managing heart d

2 views • 30 slides


Revolutionizing Brain Health Monitoring and Intervention with AI

Willow Health presents an innovative AI companion, Willow, designed for personalized brain health monitoring and intervention. Their team, comprising students, scientists, doctors, and entrepreneurs, is dedicated to advancing brain health through continuous monitoring and improvement using digital a

2 views • 17 slides


Biomarker and Companion Diagnostics Conference -USA (20th - 21st June 2024)

MarketsandMarkets brings to you the Biomarker and Companion Diagnostics Conference scheduled to be held on 20th - 21st June 2024 in Boston, USA. This event will have an introduction to turning biomarkers into companion diagnostics.\n\nBecome a Speaker @ \/\/events.marketsandmarkets.com\/2nd-annual-b

1 views • 6 slides


Biomarkers Market Trend to be Worth $201.33 Billion by 2031

Biomarkers are either released by the human body in response to various diseases or by organs that are affected by the disease, such as tumors. Biomarkers are being used increasingly to detect several infectious and chronic diseases, such as cancer, neurological disorders, cardiovascular diseases, a

0 views • 2 slides


Global Renal Biomarkers Market

The Global Renal Biomarkers Market Size is Anticipated to Exceed USD 3,081.6 Million by 2033, Growing at a CAGR of 7.53% from 2023 to 2033.\n\n

0 views • 5 slides


Effect of Semaglutide on Aging Biomarkers in Older Adults

Semaglutide, a GLP-1 receptor agonist, shows promising effects on physical function, body composition, and aging biomarkers in older adults with diabetes. Studies suggest potential neuroprotective effects, improvement in skeletal muscle atrophy, and reduction in pro-inflammatory markers. Diabetes pr

0 views • 23 slides


digital biomarkers market

The Global Digital Biomarkers Market size is expected to be worth around USD 24.3 Billion by 2033, from USD 3.4 Billion in 2023, growing at a CAGR of 21.7% during the forecast period from 2024 to 2033.

0 views • 2 slides


Understanding Basic Concepts in Industrial Toxicology

Industrial toxicology is a vital field that studies the effects of various agents on organism health through mechanisms of action, toxicokinetics, and more. It explores toxic chemical absorption, distribution, metabolism, and elimination, as well as toxic effects on major organ systems. Learn about

0 views • 35 slides


Translational Liver Cancer Research Initiatives

Translational Liver Consortia (TLC) and the Translational Hepatocellular Carcinoma Consortium (THCCC) led by Dr. Hashem B. El-Serag are focused on advancing research for early detection of liver cancer. The main objectives include patient stratification for liver cancer risk, surveillance in cirrhos

0 views • 25 slides


Comprehensive Overview of Dementia Treatment Strategies

Dementia, a syndrome resulting from various diseases affecting nerve cells and brain function, leads to cognitive decline. Treatment approaches include pharmacological and non-pharmacological interventions such as biomarker monitoring, lifestyle modifications, and addressing risk factors like hypert

0 views • 12 slides


EASL Clinical Practice Guidelines for Drug-Induced Liver Injury Management

These slides provide an in-depth overview of the EASL clinical practice guidelines on managing drug-induced liver injury. The guidelines cover epidemiology, key recommendations, future prospects, new biomarkers, unresolved issues, and unmet needs. Recommendations are based on evidence levels from th

0 views • 44 slides


Understanding Biomarkers in Therapeutic Innovation

European Patients Academy on Therapeutic Innovation explains how biomarkers are measurable indicators providing insights into health conditions. Biomarkers like glucose levels in diabetes management and MRI imaging for Multiple Sclerosis play crucial roles. The Academy aims to enhance the medicine d

0 views • 24 slides


Opportunities for Undergraduates in Health Research Lab

The Mohan Research Lab offers undergraduates the chance to conduct impactful research that can be published, focusing on biomarkers and targets for autoimmune diseases and cancers. Led by an international team of researchers, the lab provides a collaborative environment for students to engage in cut

4 views • 12 slides


Enhancing Cancer Surveillance in Colorado: Statewide Biomarker Collection

Colorado's comprehensive cancer programs are focusing on enhancing cancer surveillance by collecting biomarkers and prognostic factors statewide. The initiative involves multi-phase implementation, bidirectional reporting for genetic counseling services, and increasing testing for targeted therapies

4 views • 17 slides


Australian Imaging Biomarkers and Lifestyle Study: Progress and Focus

The Australian Imaging Biomarkers and Lifestyle Study of Ageing (AIBL) commenced in late 2006, with a cohort size and follow-up progress detailed. The study includes assessments and biomarker imaging, such as MRI, amyloid PET, and tau PET scans, with ongoing review cycles and data additions. Current

0 views • 12 slides


Alzheimer’s Drugs Market

growing research activities in developing countries, increase in awareness programs, initiatives by public and private organizations, use of combination drug therapy, and use of biomarkers and imaging techniques for diagnosis and management are expected to offer growth opportunities.

1 views • 3 slides


Collaborative Project: Circulating Autoantibody Biomarkers for Early Detection of Ovarian Cancer

This collaborative project aims to utilize circulating autoantibody biomarkers for the early detection of ovarian cancer, highlighting the importance of screening due to the high curability rates in early stages and the need to improve survival rates by identifying preclinical disease sooner. The pr

3 views • 31 slides


Emerging Trends in Clinical Trial Designs for Oncology Drug Development

Master protocols, seamless trials, and adaptive designs are revolutionizing oncology drug development. These innovative approaches involve multiple substudies with different objectives, evaluating investigational drugs across disease subtypes. Basket trials and umbrella trials offer flexibility in s

0 views • 13 slides


Managing Diabetes Condition with Ginger Supplements Study

The study explores the use of ginger supplements in managing diabetes, highlighting the significant impact of the disease on cost and quality of life. It includes details on the controlled crossover study conducted with participants taking ginger root powder capsules, the measurements of oxidative b

0 views • 8 slides


Pesticide Exposure Assessment in Farmers from Malaysia, Uganda, and the United Kingdom

This study evaluates the impact of pesticide exposure on farmers' health in Malaysia, Uganda, and the UK using urinary biomarker concentrations. Multiple cohorts are analyzed to assess associations between exposure-modifying factors and urine metabolite measurements. The IMPRESS project focuses on i

0 views • 12 slides


Appropriate Use Criteria for Lumbar Puncture in Alzheimer's Disease Diagnosis

Clinicians traditionally diagnose Alzheimer's Disease (AD) based on clinical criteria, but cerebrospinal fluid (CSF) AD biomarkers offer more reliable detection earlier in the disease course. This article discusses the criteria for lumbar puncture and CSF analysis in the diagnosis of AD, highlightin

0 views • 18 slides


Uncovering Brain Biomarkers Using SVD in Neuroimaging Data

Explore the methodology of hypothesis-free searching for biomarkers in large imaging datasets using Singular Value Decomposition (SVD). Dr. J. Bruce Morton and Daamoon Ghahari delve into the application of SVD and General Linear Modeling to identify potential biomarkers for ADHD and other neuropsych

0 views • 12 slides


NGM282 in NASH Phase 2: 3 mg vs 6 mg QD Randomised Trial

This Phase 2 clinical trial compares the efficacy of NGM282 (3 mg vs 6 mg) versus placebo in patients with NASH. The primary endpoint is a 5% reduction in liver fat content at 12 weeks. Randomisation was stratified by diabetes status, and stable Type 2 diabetes and lipid-lowering treatments were mai

0 views • 6 slides


Colorectal Cancer Projects Overview

This document outlines two projects conducted by the GI Collaborative Group focused on detecting and monitoring colorectal cancer using plasma protein markers and ctDNA/aberrantly methylated DNA markers. Project 1 aims to develop a panel of plasma biomarkers for the detection of adenomas and CRC, wh

0 views • 7 slides


Using Voice as a Biomarker in Disease Monitoring

This presentation proposes a new topic group on using artificial intelligence for analyzing human voice as a biomarker in disease prevention, prediction, and monitoring. The focus is on addressing challenges in developing AI solutions for clinical applications, with simulations depicting brain activ

0 views • 13 slides


Advanced Biomarker Analysis in Biogeochemistry Studies

In biogeochemistry research, advanced analytical techniques are utilized to isolate and separate organic matter, focusing on major carbon pools in bodies of water like Lake Superior. Biomarkers such as fatty acids and specific compounds are identified as indicators for various microbial processes, i

0 views • 11 slides


Alcohol Use Outcomes in Substance Use Disorder Trials

This presentation provides an in-depth overview of assessing alcohol use outcomes in substance use disorder (SUD) trials. It covers various assessment methods, common outcomes like percent days abstinent and heavy drinking days, preferred outcomes such as percentage of heavy drinking days (PHDD), an

0 views • 19 slides


Revolutionizing Healthcare: Clinical-Grade Biomarker Data Accessibility

In today's health landscape, trends show a rise in chronic diseases and an aging population, leading to a decentralized healthcare approach. Introducing EGOO, a mobile test unit with smart software for personalized diagnostics. With easy sampling methods and advanced optics to measure biomarkers, it

0 views • 25 slides


Circulating miRNA Changes in Alzheimer's and Parkinson's Diseases Analysis Workshop

Workshop focused on analyzing circulating miRNA changes associated with Alzheimer's and Parkinson's diseases using the Genboree Workbench and exceRpt small RNA-seq analysis pipeline. The study aimed to identify extracellular miRNA biomarkers correlating with disease status and progression, replicati

0 views • 20 slides


Australian Imaging Biomarkers and Lifestyle Study Overview

The Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing began in 2006 with PiB and MRI assessments. Over time, the study has expanded to include more participants and various imaging modalities. Current focuses include converting amyloid results to centiloid units, exploring blood b

1 views • 7 slides


Role of Serosurveillance in Assessing Vaccination History

This presentation discusses the use of serosurveillance in household surveys to supplement vaccination data collection by testing for biomarkers indicative of vaccination history. It explores the ideal biomarker for vaccination, differences between serosurveillance and vaccination coverage, limitati

0 views • 8 slides


Understanding Biomarkers and Maturity Parameters in Petroleum Exploration

Biomarkers and maturity parameters play crucial roles in characterizing source materials and assessing the thermal maturity of organic matter in petroleum exploration. Specific biomarkers and non-biomarker maturity parameters are utilized to determine the relative maturity of source rocks and oils.

0 views • 17 slides


Evaluation Methods for Liver Steatosis in Obese Children

This study examines the assessment of liver steatosis in obese children using MRI, ultrasound, and biology techniques, evaluating methods such as attenuation coefficient and proton density fat fraction. The aim is to develop noninvasive biomarkers and validate existing scores for predicting NAFLD. P

0 views • 22 slides


Initial Looks at ADNI3 and Analysis Update - Biostatistics Core Goals and New Measurement

This update discusses the goals of the Biostatistics Core in integrating data from various sources for clinical trial design, assessing biomarkers and clinical measures, and identifying subgroups in MCI. The update also introduces a new measurement, the Financial Capacity Instrument, and shares prel

0 views • 22 slides


Precision Medicine Approach for Post-cardiac Arrest Care Study

Study aims to develop novel biomarkers for optimizing hypothermia duration post-cardiac arrest and predicting 90-day function. Overcoming past limitations in neuroprognostication research, the study utilizes a multicenter approach and standardizes post-resuscitation care protocols. Addressing challe

0 views • 13 slides


Breast Cancer Research Projects Overview

Ongoing breast cancer research projects focusing on biomarker validation, new team initiatives, and imaging advancements are detailed. Notable efforts include the investigation of triple-negative breast cancer markers, benign breast disease progression markers, ER+ and HER2+ biomarkers, and breast c

0 views • 9 slides


Revolutionizing Quantitative Imaging Biomarkers with QIBA-Japan Collaboration

Explore the expectations and initiatives of QIBA in Japan, focusing on improving biomarkers, enhancing clinical decisions, and setting standards for performance metrics. Learn how QIBA aims to address sources of variance, optimize procedures, and ensure quality in radiological imaging practices.

0 views • 19 slides


Prostate Collaborative Group Research Efforts Overview

The Prostate Collaborative Group is actively working on various research projects related to the detection and evaluation of prostate cancer biomarkers. Updates on research statuses, innovative imaging and urine testing methods, development of protein biomarkers, and biomarkers for early detection o

0 views • 8 slides